Treatment of Low-Blast Count AML using Hypomethylating Agents

In 2002, the WHO classification reduced the proportion of blasts in the bone marrow (BM) necessary for the diagnosis of acute myeloid leukemia (AML) from 30% to 20%, eliminating the RAEB-t subtype of myelodysplastic syndromes (MDS). However, this AML subtype, defined as low-blast count AML (LBC-AML,...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Mediterr J Hematol Infect Dis
Päätekijät: De Bellis, Eleonora, Fianchi, Luana, Buccisano, Francesco, Criscuolo, Marianna, Maurillo, Luca, Cicconi, Laura, Brescini, Mattia, Del Principe, Maria Ilaria, Di Veroli, Ambra, Venditti, Adriano, Amadori, Sergio, Arcese, William, Lo-Coco, Francesco, Voso, Maria Teresa
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Università Cattolica del Sacro Cuore 2017
Aiheet:
Review Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5499495/
https://ncbi.nlm.nih.gov/pubmed/28698788
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4084/MJHID.2017.045
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia